Forsell Marlene

Member of the Board and Chairman of the Audit Committee på Nobia AB

📍 Stockholm County, Sweden🔄 Updated September 2026💼 6 investments📅 12 years investing🗓 Last invested May 2025
Angel investor🌍 Sweden
6
Total investments
0
Early stage
0
Mid stage
0
Late stage
12y
Years active

Portfolio

0 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience · 6 entries
All (6)
Investments (6)
Board (6)
2025
Member of the Board
May 2025
NCAB Group is a leading global producer of printed circuit boards, also referred to as PCBs. As a leading PCB supplier, we work closely with both our customers and our factories to produce reliable circuit boards in a sustainable way at the lowest total cost through our competence, delivery accuracy and product quality. At NCAB Group, we serve demanding customers for whom the PCB is a strategic product throughout the entire product life cycle. We therefore make sure that our specialists oversee that the production – from design to prototyping up to volume – is working according to our processes and product specification. We make sure that your PCBs are not only reliable, but also delivered on time. NCAB Group is a global company with offices in 19 countries all over the world. This allows us to offer competitive terms, quality, and delivery assurance that broaden your production possibilities. We also work with a wide range of PCBs. The different types of PCBs in our portfolio includes Flex PCBs, HDI PCBs, multilayer PCBs and more. For more information about NCAB Group, visit our company site at www.ncabgroup.com , or our career site at www.ncabgroup.com/career/ And if you’re interested in becoming a customer, or want to get into contact, you can reach us at www.ncabgroup.com/contact/
2023
Member of the Board
Oct 2023
At Viedoc, we design engaging software that modernizes clinical research so that necessary treatments can reach the people who need them faster. We believe in life and science, in people, and in our collective power to change the world and build a healthier future. That unmatched driving force is what pushes us to innovate, accelerate and improve every aspect of modern clinical studies. Since 2003, Viedoc has united scientists and clinical trial professionals in a shared mission of pushing life-changing research forward. Our solution has been used to power thousands of studies, by collecting data from over a million patients and allowing it to flow smoothly across sites and countries. We take great pride in helping bridge the gap between patient and researcher – and, in the best of cases, between research and breakthrough.
2021
Member of the Board
Mar 2021
AddSecure is a leading European provider of secure IoT connectivity and end-to-end solutions. We help customers optimize their operations, drive business value, and secure vital functions. By combining connected, data-driven, and sensor-based solutions with best-in-class expertise, we meet our customers’ needs regardless of industry. We provide both managed services and connect any device in need of secure communications and data transfer. Imagination is the only limit. Our secure IoT solutions are used within the areas of buildings, alarms, transportation and logistics, personal safety and security, health care, construction, municipalities, schools, rescue services, power grids, and more. AddSecure’s headquarters is in Stockholm, Sweden. Our main market is Europe, yet we serve customers worldwide. With over 1, 100 employees, we help make the world safer, smarter, and more sustainable. Want to join us to make a difference? If you seek a company that encourages you to be yourself and to have fun at work, where your work contributes to a safer, smarter, and more sustainable world, then AddSecure might be your destination. Join our growing international team, where each day is an opportunity to make a real difference. Find job opportunities and get to know our culture: Join AddSecure - https://career.addsecure.com/
2020
Member of the Board
Apr 2020
InDex Pharmaceuticals in brief InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options. The company’s lead asset is the drug candidate cobitolimod, which is being evaluated in the phase III study CONCLUDE as a novel treatment of moderate to severe ulcerative colitis – a debilitating, chronic inflammation of the large intestine. InDex has also developed a platform of patent protected discovery stage substances, so called DNA based ImmunoModulatory Sequences (DIMS), with the potential to be used in the treatment of various immunological diseases. InDex is based in Stockholm, Sweden. The company’s shares (ticker INDEX) are traded on Nasdaq First North Growth Market Stockholm.
2015
Arnold Andre Gmbh
Member of the Board (incl audit committee)
Jun 2015
Show all 6 entries ↓
Investment activity
2014–2025 · 6 investments
201412015120201202112023120251
Recent (last 2 years)Earlier